CVS Health Files 8-K on Shareholder Votes

Ticker: CVS · Form: 8-K · Filed: 2025-05-20T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, 8-k

Related Tickers: CVS

TL;DR

CVS filed an 8-K on shareholder votes, standard corporate update.

AI Summary

CVS Health Corporation filed an 8-K on May 20, 2025, reporting on matters submitted to a vote of security holders as of May 15, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).

Why It Matters

This filing provides transparency regarding corporate governance and shareholder decisions, which can influence investor confidence and company strategy.

Risk Assessment

Risk Level: low — This is a routine corporate filing regarding shareholder votes and does not indicate any immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of CVS Health's security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 15, 2025.

What is CVS Health Corporation's state of incorporation?

CVS Health Corporation is incorporated in Delaware.

What is the IRS Employer Identification Number (EIN) for CVS Health Corporation?

The IRS Employer Identification Number for CVS Health Corporation is 05-0494040.

What is the principal executive office address for CVS Health Corporation?

The principal executive office address for CVS Health Corporation is One CVS Drive, Woonsocket, Rhode Island 02895.

From the Filing

0000064803-25-000015.txt : 20250520 0000064803-25-000015.hdr.sgml : 20250520 20250520161256 ACCESSION NUMBER: 0000064803-25-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250515 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250520 DATE AS OF CHANGE: 20250520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 25968860 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 cvs-20250515.htm 8-K cvs-20250515 0000064803 false 0000064803 2025-05-15 2025-05-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2025 ( May 15, 2025 ) CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-01011 05-0494040 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One CVS Drive , Woonsocket , Rhode Island 02895 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Former name or former address, if changed since last report: N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share CVS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act . ☐ Section 5 - Corporate Governance and Management Item 5.07 Submission of Matters to a Vote of Security Holders. The following are the voting results on each matter submitted to the stockholders of CVS Health Corporation (the “Company”) at the Annual Meeting of Stockholders held on May 15, 2025 (the “Annual Meeting”). The proposals below are described in detail in the proxy statement filed by the Company on April 4, 2025 (the “Proxy Statement”). There were present at the Annual Meeting, in person or by valid proxy, the holders of 1,125,353,195 shares of the Company’s common stock, constituting a quorum. At the Annual Meeting, the 13 nominees for director w

View on Read The Filing